Sorted news

Rydapt approved for adults with acute myeloid leukemia

(HealthDay)—Rydapt (midostaurin) has been approved by the U.S. Food and Drug Administration, in combination with chemotherapy, to treat adults with acute myeloid leukemia (AML) who have a specific genetic mutation dubbed ...

12 hours ago
popularity0 comments 0